Stocktoria
IDEXX LABORATORIES INC /DE IDXX
Nasdaq · stock · In Vitro & In Vivo Diagnostic Substances · website · IPO 1991-06-21
IDEXX LABORATORIES INC /DE institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 9,603,226 | $4.7B | 11.85% |
| Point72 Asset Management, L.P. | 264,005 | $139.0M | 0.33% |
| RENAISSANCE TECHNOLOGIES LLC | 109,784 | $57.8M | 0.14% |
| MILLENNIUM MANAGEMENT LLC | 97,080 | $51.1M | 0.12% |
| AQR CAPITAL MANAGEMENT LLC | 77,198 | $40.4M | 0.1% |
| CITADEL ADVISORS LLC | 67,246 | $35.4M | 0.08% |
| Bridgewater Associates, LP | 33,528 | $17.7M | 0.04% |
| TWO SIGMA INVESTMENTS, LP | 1,020 | $536,969 | — |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.